3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
3
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Somatostatinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Mesothelioma, Malignant
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Insulinoma
1
Immunoblastic Lymphadenopathy
1
Glucagonoma
1
Interventions
Ifosfamide
5
Doxorubicin
4
Specimen Handling
3
Methotrexate
3
Etoposide
3
Cisplatin
3
Sorafenib
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
sodium thiosulfate
1
sargramostim
1
pepinemab
1
peginterferon alfa-2b
1
mifamurtide
1
merphos
1
lorukafusp alfa
1
irinotecan sucrosofate
1
imetelstat
1
etoposide phosphate
1
Zoledronic Acid
1
X-Rays
1
Thrombopoietin
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Razoxane
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Osteosarcoma
×
Everolimus
×
Clear all
NCT01804374
2015-06-17
SERIO
Italian Sarcoma Group
Phase 2
Completed
38 enrolled